Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis

I. Hainerova, L.H. Larsen, B. Holst, M. Finkova, V. Hainer, J. Lebl, T. Hansen, O. Pedersen

. 2007 ; 92 (9 Sep) : 3689-3696.

Language English Country United States

Document type Comparative Study

E-resources Online

NLK Free Medical Journals from 1997 to 1 year ago

BACKGROUND: Mutations in the melanocortin 4 receptor gene (MC4R) represent the most common known cause of monogenic human obesity. AIMS: The aims of this study were the following: 1) to estimate the prevalence of MC4R mutations in obese Czech children; 2) to evaluate phenotypic features of the mutation carriers; 3) to compare weight, height, and body mass index of MC4R mutation carriers with noncarriers in longitudinal studies; 4) to determine the effect of a weight management program among MC4R mutation carriers; and 5) to perform a functional analysis of a novel variant. SUBJECTS AND METHODS: We analyzed the coding region of MC4R in a cohort of 289 Czech children and adolescents with early-onset obesity by direct sequencing. Information on weight, height, body mass index, baseline biochemical data, and a weight loss follow-up study was obtained. In vitro functional analysis of one novel variant was performed. RESULTS: We identified six different mutations in seven probands: one novel missense mutation Cys84Arg and five previously reported variants, Arg7Cys, Ser19fsdelA, Phe51Leu, Ser127Leu, and Gly181Asp. The Gly181Asp variant was detected in one homozygous carrier from unrelated parents. None of the mutation carriers fulfilled the MC4R syndrome criteria. A comparison of anthropometrics in mutation carriers and noncarriers during 13 yr of follow-up did not reveal any significant differences. MC4R mutation carriers exhibited a similar ability to lose weight as obese noncarriers. The novel variant Cys84Arg showed a significant reduction in cAMP signal properties of the MC4R. CONCLUSIONS: Among obese Czech children, we found a prevalence of 2.4% of MC4R homozygous and heterozygous mutations and showed a similar response to diet management of MC4R mutation carriers and noncarriers.

000      
03971naa 2200577 a 4500
001      
bmc10012706
003      
CZ-PrNML
005      
20121112124833.0
008      
100526s2007 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Aldhoon Hainerová, Irena, $7 xx0062316 $d 1978-
245    10
$a Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis / $c I. Hainerova, L.H. Larsen, B. Holst, M. Finkova, V. Hainer, J. Lebl, T. Hansen, O. Pedersen
314    __
$a Department of Pediatrics and Center for Research of Diabetes, Metabolism, and Nutrition, Third Faculty of Medicine, Charles University, 100 34 Prague 10, Czech Republic. ihainer@hotmail.com
520    9_
$a BACKGROUND: Mutations in the melanocortin 4 receptor gene (MC4R) represent the most common known cause of monogenic human obesity. AIMS: The aims of this study were the following: 1) to estimate the prevalence of MC4R mutations in obese Czech children; 2) to evaluate phenotypic features of the mutation carriers; 3) to compare weight, height, and body mass index of MC4R mutation carriers with noncarriers in longitudinal studies; 4) to determine the effect of a weight management program among MC4R mutation carriers; and 5) to perform a functional analysis of a novel variant. SUBJECTS AND METHODS: We analyzed the coding region of MC4R in a cohort of 289 Czech children and adolescents with early-onset obesity by direct sequencing. Information on weight, height, body mass index, baseline biochemical data, and a weight loss follow-up study was obtained. In vitro functional analysis of one novel variant was performed. RESULTS: We identified six different mutations in seven probands: one novel missense mutation Cys84Arg and five previously reported variants, Arg7Cys, Ser19fsdelA, Phe51Leu, Ser127Leu, and Gly181Asp. The Gly181Asp variant was detected in one homozygous carrier from unrelated parents. None of the mutation carriers fulfilled the MC4R syndrome criteria. A comparison of anthropometrics in mutation carriers and noncarriers during 13 yr of follow-up did not reveal any significant differences. MC4R mutation carriers exhibited a similar ability to lose weight as obese noncarriers. The novel variant Cys84Arg showed a significant reduction in cAMP signal properties of the MC4R. CONCLUSIONS: Among obese Czech children, we found a prevalence of 2.4% of MC4R homozygous and heterozygous mutations and showed a similar response to diet management of MC4R mutation carriers and noncarriers.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a tělesná výška $x genetika $7 D001827
650    _2
$a tělesná hmotnost $x genetika $7 D001835
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a frekvence genu $7 D005787
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a biologické modely $7 D008954
650    _2
$a mutace $7 D009154
650    _2
$a obezita $x dietoterapie $x genetika $x patofyziologie $7 D009765
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
650    _2
$a receptor melanokortinový typ 4 $x genetika $7 D044105
650    _2
$a receptor melanokortinový typ 4 $x fyziologie $7 D044105
650    _2
$a hmotnostní úbytek $x fyziologie $7 D015431
650    _2
$a financování organizované $7 D005381
651    _2
$a Česká republika $7 D018153
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Larsen, Lesli H.
700    1_
$a Holst, Birgitte
700    1_
$a Finková, Marie $7 xx0074812
700    1_
$a Hainer, Vojtěch, $d 1944- $7 jn19990209207
700    1_
$a Lebl, Jan, $d 1955- $7 jn19990010093
700    1_
$a Hansen, Torben
700    1_
$a Pedersen, Oluf
773    0_
$t Journal of Clinical Endocrinology & Metabolism $w MED00002582 $g Roč. 92, č. 9 Sep (2007), s. 3689-3696 $x 0021-972X
910    __
$a ABA008 $b x $y 8
990    __
$a 20100531100600 $b ABA008
991    __
$a 20121112124847 $b ABA008
999    __
$a ok $b bmc $g 726561 $s 589718
BAS    __
$a 3
BMC    __
$a 2007 $b 92 $c 9 Sep $d 3689-3696 $i 0021-972X $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
LZP    __
$a 2010-B2/vtme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...